MKI67 and neoplasm: Our evaluation of the Ki67 score to gauge tumor aggressiveness parallels findings from Soliman et al., who demonstrated a quantitative association between Ki67 percentages and recurrence and overall survival, reporting notably poor outcomes with Ki67 scores above 15% [15].